Skip to search formSkip to main contentSkip to account menu

Insulin, Glulisine, Human

Known as: insulin, Lys(B3)-Glu(B29)-, glulisine insulin, INSULIN GLULISINE 
A drug used to control the amount of sugar in the blood of patients with diabetes mellitus. It is a form of the hormone insulin that is made in the… 
National Institutes of Health

Related topics

Related topics

13 relations
3 ML Insulin, Glulisine, Human 100 UNT/ML Pen Injector3 ML Insulin, Glulisine, Human 100 UNT/ML Pen Injector [Apidra]Decreased Lipolysis [PE]Diabetes Mellitus, Insulin-Dependent

Narrower (1)

Apidra

Broader (2)

Hypoglycemic AgentsInsulin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Use of a basal-plus insulin regimen in persons with type 2 diabetes stratified by age and body mass index: A pooled analysis of four clinical trials.
Review
2011
Review
2011
A Pan-European and Canadian Prospective Survey to Evaluate Patient Satisfaction with the SoloSTAR Insulin Injection Device in Type 1 and Type 2 Diabetes
Objective: This study evaluated patient satisfaction with SoloSTAR® (sanofi-aventis), a prefilled insulin pen device for… 
2011
2011
Do Different Body Colors and Labels of Insulin Pens Enhance a Patient's Ability to Correctly Identify Pens for Injecting Long-Acting versus Short-Acting Insulins?
Background: The objective of this study was to characterize how successfully patients with diabetes are able to distinguish… 
2009
2009
Dose–response relationship of insulin glulisine in subjects with type 1 diabetes
Aim:  Little is known about the dose–response relationships of rapid‐acting insulin analogues in subjects with diabetes. This… 
2009
2009
Efficacy and safety of insulin glulisine in Japanese patients with type 1 diabetes mellitus
Aim: The rapid‐acting insulin analogue insulin glulisine (glulisine) was compared with insulin lispro (lispro) for efficacy and… 
2008
2008
A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
Review
2007
Review
2007
Dose accuracy and injection force dynamics of a novel disposable insulin pen
SoloStar® (sanofi-aventis) is a new, disposable insulin pen for the administration of insulin glargine (Lantus®, sanofi-aventis… 
2006
2006
Insulin Glulisine—A Comprehensive Preclinical Evaluation
Receptor binding and signaling and the mitogenic potential of insulin glulisine (glulisine), regular human insulin (RHI), and Asp… 
2005
2005
Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors
Aims/hypothesisNew insulin analogues have been created by amino-acid exchange to provide an improved pharmacokinetic profile… 
Review
2003
Review
2003
Insulin glulisine. Aventis Pharma.
Aventis Pharma (formerly Hoechst Marion Roussel) is developing insulin glulisine, a fast-acting insulin analog, for the potential… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)